Abstract
In a prospective randomized study, children with Haemophilus influenzae type b meningitis received moxalactam or ampicillin or chloramphenicol. Of 41 children, 6 had prolonged bleeding times (greater than 6 min), and 7 of 9 tested had abnormal platelet aggregation at hospital admission. At the end of therapy, no children in the ampicillin-chloramphenicol group, compared with 5 of 22 moxalactam-treated children (23%) (P = 0.08), had prolonged bleeding times (6.5 to 7.5 min). Our data suggest that H. influenzae meningitis and treatment with moxalactam may each have an effect on platelet function in children.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bang N. U., Tessler S. S., Heidenreich R. O., Marks C. A., Mattler L. E. Effects of moxalactam on blood coagulation and platelet function. Rev Infect Dis. 1982 Nov-Dec;4 (Suppl):S546–S554. doi: 10.1093/clinids/4.supplement_3.s546. [DOI] [PubMed] [Google Scholar]
- Brown C. H., 3rd, Natelson E. A., Bradshaw W., Williams T. W., Jr, Alfrey C. P., Jr The hemostatic defect produced by carbenicillin. N Engl J Med. 1974 Aug 8;291(6):265–270. doi: 10.1056/NEJM197408082910601. [DOI] [PubMed] [Google Scholar]
- Chan-Lui W. Y., Stroebel A. B., Yeung C. Y. Hemorrhagic tendency as a complication of Moxalactam therapy in bacterial meningitis. Brain Dev. 1983;5(4):417–420. doi: 10.1016/s0387-7604(83)80048-5. [DOI] [PubMed] [Google Scholar]
- Chartrand S. A., Marks M. I., Scribner R. K., Johnston J. T., Frederick D. F. Moxalactam therapy of Haemophilus influenzae type b meningitis in children. J Pediatr. 1984 Mar;104(3):454–459. doi: 10.1016/s0022-3476(84)81116-6. [DOI] [PubMed] [Google Scholar]
- Kaplan S. L., Mason E. O., Jr, Kvernland S. J., Calaway E. L., Feigin R. D. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations. Rev Infect Dis. 1982 Nov-Dec;4 (Suppl):S597–S602. [PubMed] [Google Scholar]
- Kaplan S. L., Mason E. O., Jr, Kvernland S. J., Loiselle E. M., Feigin R. D. Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. Pediatrics. 1983 Feb;71(2):187–191. [PubMed] [Google Scholar]
- Kaplan S. L., Mason E. O., Jr, Mason S. K., Catlin F. I., Lee R. T., Murphy M., Feigin R. D. Prospective comparative trial of moxalactam versus ampicillin or chloramphenicol for treatment of Haemophilus influenzae type b meningitis in children. J Pediatr. 1984 Mar;104(3):447–453. doi: 10.1016/s0022-3476(84)81115-4. [DOI] [PubMed] [Google Scholar]
- Lipsky J. J., Lewis J. C., Novick W. J., Jr Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats. Antimicrob Agents Chemother. 1984 Mar;25(3):380–381. doi: 10.1128/aac.25.3.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCracken G. H., Jr, Threlkeld N., Mize S., Baker C. J., Kaplan S. L., Faingezicht I., Feldman W. E., Schaad U. Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation. JAMA. 1984 Sep 21;252(11):1427–1432. [PubMed] [Google Scholar]
- Mielke C. H., Jr Influence of aspirin on platelets and the bleeding time. Am J Med. 1983 Jun 14;74(6A):72–78. doi: 10.1016/0002-9343(83)90532-6. [DOI] [PubMed] [Google Scholar]
- Pakter R. L., Russell T. R., Mielke C. H., West D. Coagulopathy associated with the use of moxalactam. JAMA. 1982 Sep 3;248(9):1100–1100. [PubMed] [Google Scholar]
- Saba H. I., Saba S. R., Morelli G., Hartmann R. C. Endotoxin-mediated inhibition of human platelet aggregation. Thromb Res. 1984 Apr 1;34(1):19–33. doi: 10.1016/0049-3848(84)90103-8. [DOI] [PubMed] [Google Scholar]
- Weitekamp M. R., Aber R. C. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA. 1983 Jan 7;249(1):69–71. [PubMed] [Google Scholar]